1. Home >
  2. Investors >
  3. Private Equity Firm >
  4. United States >
  5. New York >
  6. OrbiMed Advisors >
  7. M&A

OrbiMed Advisors Mergers & Acquisitions

OrbiMed Advisors M&A Summary

The Firm’s most common exit type is ipo (50%). OrbiMed Advisors’ largest (disclosed) exit occurred in 2018 when it sold GENEWIZ for $450M.

Sign-up to view OrbiMed Advisors’ full profile and discover more large private equity firm investors just like it.

M&A Summary

  • M&A Total Activity10
    • M&A Buy Activity6
    • M&A Sell Activity4
  • M&A Buy/Sell Connections6

OrbiMed Advisors LLC

601 Lexington Avenue, 54th Floor,
New York, New York 10022
United States
(212) 739-6400
www.orbimed.com
info@orbimed.com

All (10) Buy (6) Sell (4)
Date Target Value
$mlns 		Transaction Type Acquirer Seller SRC
Link
2022-11-02 Compass Therapeutics · Life Science
Boston, United Kingdom · www.compasstherapeutics.com

Compass Therapeutics is a clinical-stage biopharmaceutical company developing proprietary antibody therapeutics to treat both solid tumors and hematologic malignancies. Compass is leveraging its proprietary StitchMabs™ and common light-chain-based multispecific platforms to empirically identify multispecific and combinations of antibody therapeutics that synergistically modulate key nodes in the immune system. Compass Therapeutics was incorporated in 2014 and is based in Boston, Massachusetts.

- Stake Purchase

Enavate Sciences

OrbiMed Advisors LLC PE

Vivo Capital PE

-

Try Mergr Free — See This and 221,377+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 215K M&A Transactions
  • 217K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal